<DOC>
	<DOC>NCT01062360</DOC>
	<brief_summary>The purpose of this study is compare efficacy and tolerability of a fixed combination, containing 500 mg Acetylsalicylic acid and 30 mg Pseudoephedrine, in comparison to its single components in patients with sore throat and nasal congestion.</brief_summary>
	<brief_title>Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine</brief_title>
	<detailed_description />
	<mesh_term>Common Cold</mesh_term>
	<mesh_term>Pharyngitis</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<criteria>Male and female subjects between 18 and 65 years of age. Onset of cold symptoms within 96 hours (4 days) before study participation. Current complaint of at least moderate sore throat at baseline Current complaint of at least moderate NC at baseline History of other symptoms associated with URTI during the last 4 days before study participation. Other findings of URTI, confirmed on the physical examination. Agreement to comply with the study requirements. Written informed consent prior to enrollment in the study Pregnant or lactating females. Uncontrolled chronic diseases. History of hypersensitivity (allergic reaction) to ASA, any other nonsteroidal antiinflammatory drugs (NSAIDs), or PSE. Any disease which significantly compromises breathing or interferes with the subjects assessment of sore throat. History of or active peptic ulcer. Severe impaired hepatic function. Severe impaired renal function. Simultaneous intake of monoamine oxidase inhibitors. Use of menthol containing tissues within 2 hours before first intake of study drug. Intake of any menthol containing product within 4 hours before first intake of study drug. Use of any local or systemic short acting cough and cold preparations within 6 hours before first intake of study drug. Use of any local or systemic long acting cough and cold preparations within 12 hours before first intake of study drug. Intake of any analgesic within 12 hours before first intake of study drug. Intake or requirement of any prescription medication for the treatment of the current acute respiratory tract infection. Current or previous intake of anticoagulants, corticoids, NSAIDs, methotrexate, or lithium. Participation in another clinical trial within the last 30 days.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Sore Throat</keyword>
	<keyword>Upper Respiratory Tract Infections</keyword>
	<keyword>Nasal Congestion</keyword>
</DOC>